Target Price | $5.61 |
Price | $0.42 |
Potential |
1,235.71%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Aspira Women`s Health Inc 2026 .
The average Aspira Women`s Health Inc target price is $5.61.
This is
1,235.71%
register free of charge
$5.78
1,275.00%
register free of charge
$5.56
1,222.62%
register free of charge
|
|
A rating was issued by 5 analysts: 4 Analysts recommend Aspira Women`s Health Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Aspira Women`s Health Inc stock has an average upside potential 2026 of
1,235.71%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 9.18 | 18.34 |
0.33% | 99.80% | |
Net Margin | -142.59% | -54.64% |
21.83% | 61.68% |
4 Analysts have issued a sales forecast Aspira Women`s Health Inc 2025 . The average Aspira Women`s Health Inc sales estimate is
This results in the following potential growth metrics:
4 Aspira Women`s Health Inc Analysts have issued a net profit forecast 2025. The average Aspira Women`s Health Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.93 | -0.58 |
48.62% | 37.63% | |
P/E | negative | |
EV/Sales | 0.78 |
4 Analysts have issued a Aspira Women`s Health Inc forecast for earnings per share. The average Aspira Women`s Health Inc EPS is
This results in the following potential growth metrics and future valuations:
Aspira Women`s Health Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.